Sanofi (SNY) Other Non-Current Liabilities (2009 - 2025)

Sanofi has disclosed Other Non-Current Liabilities across 17 years of filings, most recently posting $7.8 billion for Q4 2025.

• Other Non-Current Liabilities for Q4 2025 came in at $7.8 billion, down 9.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.8 billion (down 9.81% YoY), and the FY2025 annual result was $7.8 billion, down 9.81% from the prior year.
• Other Non-Current Liabilities came in at $7.8 billion for Q4 2025 at Sanofi, down from $8.1 billion in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $8.9 billion in Q2 2024 to a low of $1.3 billion in Q4 2022.
• The 5-year median for Other Non-Current Liabilities is $7.9 billion (2025), against an average of $6.7 billion.
• Across the five-year window, Other Non-Current Liabilities decreased 28.44% in 2021 and jumped 550.2% in 2023, its largest moves.
• Sanofi's Other Non-Current Liabilities stood at $1.3 billion in 2021, then slipped by 1.64% to $1.3 billion in 2022, then surged by 550.2% to $8.2 billion in 2023, then grew by 5.77% to $8.7 billion in 2024, then decreased by 9.81% to $7.8 billion in 2025.
• The last three Other Non-Current Liabilities figures came in at $7.8 billion (Q4 2025), $8.1 billion (Q2 2025), and $8.7 billion (Q4 2024), per Business Quant data.